Clinical Outcomes and Medical Care Costs Among Medicare Beneficiaries Receiving Therapy for Peripheral Arterial Disease

Peripheral Arterial Testing Before Lower Extremity Amputation Among Medicare Beneficiaries, 2000 to 2010

“…11,12 We defined PAD on the basis of any diagnosis code or procedure code for revascularization. 7,13 We also searched carrier claims for outpatient evaluation and management visits with a vascular specialist, excluding service in an inpatient hospital or emergency department (Table in the Data Supplement). We identified vascular specialists using the Health Care Financing Administration specialty code on the carrier claim, including cardiologists, peripheral vascular disease specialists, vascular surgeons, and interventional radiologists (Table in the Data Supplement).…”

Novel screening metric for the identification of at-risk peripheral artery disease patients using administrative claims data

“…This algorithm was based on a thorough review of the literature. 4,10,[22][23][24] These codes indicate reasonable diagnostic accuracy in identifying PAD cases using administrative claims data. 22 The diagnosis and procedure codes used to identify PAD and non-PAD cases are listed in Appendix A.…”

“…However, a thorough review of the literature led to the development of our claims-based algorithm to identify PAD, 4,10,22,23 which had been shown to have reasonable diagnostic accuracy. 22 Further studies to confirm the predictive value of this screening tool using an ABI would be useful.…”

Vorapaxar in patients with peripheral artery disease and acute coronary syndrome: Insights from Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER)

“…9,10 The performance of these procedures is costly, and LE amputation specifically is associated with disability, morbidity, and ultimately mortality. [11][12][13] A significant treatment gap exists for the reduction of peripheral complications in PAD, and novel treatment strategies are needed.…”